Document Detail


Superoxide dismutase mimetic, MnTE-2-PyP, attenuates chronic hypoxia-induced pulmonary hypertension, pulmonary vascular remodeling, and activation of the NALP3 inflammasome.
MedLine Citation:
PMID:  23240585     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS: Pulmonary hypertension (PH) is characterized by an oxidant/antioxidant imbalance that promotes abnormal vascular responses. Reactive oxygen species, such as superoxide (O(2)(•-)), contribute to the pathogenesis of PH and vascular responses, including vascular remodeling and inflammation. This study sought to investigate the protective role of a pharmacological catalytic antioxidant, a superoxide dismutase (SOD) mimetic (MnTE-2-PyP), in hypoxia-induced PH, vascular remodeling, and NALP3 (NACHT, LRR, and PYD domain-containing protein 3)-mediated inflammation.
RESULTS: Mice (C57/BL6) were exposed to hypobaric hypoxic conditions, while subcutaneous injections of MnTE-2-PyP (5 mg/kg) or phosphate-buffered saline (PBS) were given 3× weekly for up to 35 days. SOD mimetic-treated groups demonstrated protection against increased right ventricular systolic pressure, indirect measurements of pulmonary artery pressure, and RV hypertrophy. Vascular remodeling was assessed by Ki67 staining to detect vascular cell proliferation, α-smooth muscle actin staining to analyze small vessel muscularization, and hyaluronan (HA) measurements to assess extracellular matrix modulation. Activation of the NALP3 inflammasome pathway was measured by NALP3 expression, caspase-1 activation, and interleukin 1-beta (IL-1β) and IL-18 production. Hypoxic exposure increased PH, vascular remodeling, and NALP3 inflammasome activation in PBS-treated mice, while mice treated with MnTE-2-PyP showed an attenuation in each of these endpoints.
INNOVATION: This study is the first to demonstrate activation of the NALP3 inflammasome with cleavage of caspase-1 and release of active IL-1 β and IL-18 in chronic hypoxic PH, as well as its attenuation by the SOD mimetic, MnTE-2-PyP.
CONCLUSION: The ability of the SOD mimetic to scavenge extracellular O(2)(•-) supports our previous observations in EC-SOD-overexpressing mice that implicate extracellular oxidant/antioxidant imbalance in hypoxic PH and implicates its role in hypoxia-induced inflammation.
Authors:
Leah R Villegas; Dylan Kluck; Carlie Field; Rebecca E Oberley-Deegan; Crystal Woods; Michael E Yeager; Karim C El Kasmi; Rashmin C Savani; Russell P Bowler; Eva Nozik-Grayck
Related Documents :
12892765 - Improved outcome with novel device for low-pressure ptca in de novo and in-stent lesions.
17340105 - Detecting endoleaks after endovascular aaa repair with a minimally invasive, implantabl...
16221475 - Computational analysis of type ii endoleaks in a stented abdominal aortic aneurysm model.
9796675 - Elastic response of human iliac arteries in-vitro to balloon angioplasty using high-res...
24007975 - Intracranial atherosclerosis.
2082005 - The effect of placebo on indirect and direct blood pressure measurements.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2013-02-05
Journal Detail:
Title:  Antioxidants & redox signaling     Volume:  18     ISSN:  1557-7716     ISO Abbreviation:  Antioxid. Redox Signal.     Publication Date:  2013 May 
Date Detail:
Created Date:  2013-04-05     Completed Date:  2013-10-22     Revised Date:  2014-04-22    
Medline Journal Info:
Nlm Unique ID:  100888899     Medline TA:  Antioxid Redox Signal     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1753-64     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anoxia*
Carrier Proteins / genetics,  metabolism*
Caspase 1 / metabolism
Gene Expression
Hypertension, Pulmonary / etiology*,  prevention & control
Inflammasomes / metabolism*
Interleukin-18 / metabolism
Interleukin-1beta / metabolism
Male
Metalloporphyrins / metabolism*,  pharmacology
Mice
Pulmonary Artery / drug effects,  metabolism*,  pathology*
Superoxide Dismutase / metabolism
Grant Support
ID/Acronym/Agency:
R01 HL086680/HL/NHLBI NIH HHS; R01-HL086680/HL/NHLBI NIH HHS; R01-HL093535/HL/NHLBI NIH HHS; T32-HL007171/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/CIAS1 protein, mouse; 0/Carrier Proteins; 0/Inflammasomes; 0/Interleukin-18; 0/Interleukin-1beta; 0/Metalloporphyrins; 0/manganese tetrakis-(N-ethyl-2 pyridyl) porphyrin; EC 1.15.1.1/Superoxide Dismutase; EC 3.4.22.36/Caspase 1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antimicrobial activity of selected essential oils against cariogenic bacteria.
Next Document:  Longitudinal associations between smoking cessation medications and alcohol consumption among smoker...